IRTC240719C60000
- 34.40
- 0.000.00%
iRhythm Technologies Newsroom
Oppenheimer's Top SMID Ideas Within High-growth Themes
Despite Currently Being Unprofitable, IRhythm Technologies (NASDAQ:IRTC) Has Delivered a 57% Return to Shareholders Over 3 Years
By buying an index fund, you can roughly match the market return with ease. But many of us dare to dream of bigger returns, and build a portfolio ourselves. Just take a look at iRhythm Technologies,
Did Your Heart Skip a Beat? Your Wearable Knows. -- Barrons.com
By Bill Alpert The day is approaching when your wristwatch may send you to the hospital. The first portable electrocardiograph was an 85-pound backpack. Today, a 10-gram patch stuck on your chest ca
Heart Just Skip a Beat? Your Watch Already Knows.
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn't worry.
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Bilibili Inc. (NASDAQ:BILI) shares rose 23.32% following last week's release of 'San Guo: Mou Ding Tian Xia.'
Street Calls of the Week: Micron Downgrade, Upgrade for Kroger
IRhythm Gains as Wolfe Upgrades on Valuation
Express News | IRhythm Technologies Shares Are Trading Higher After Wolfe Research Upgraded the Stock From Peer Perform to Outperform and Announced a $115 Price Target
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
IRhythm Technologies Raised to Outperform From Peer Perform by Wolfe Research
IRhythm Technologies Raised to Outperform From Peer Perform by Wolfe Research
IRhythm Technologies Price Target Announced at $115.00/Share by Wolfe Research
IRhythm Technologies Price Target Announced at $115.00/Share by Wolfe Research
IRhythm Technologies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/20/2024 17.16% Wolfe Research → $115 Upgrades Peer Perform → Outperform 05/03/2024 24.29% Canaccord Gen
Wolfe Research Upgrades IRhythm Technologies(IRTC.US) to Buy Rating, Announces Target Price $115
Wolfe Research analyst Michael Polark upgrades $iRhythm Technologies(IRTC.US)$ to a buy rating, and sets the target price at $115.According to TipRanks data, the analyst has a success rate of 49.7% an
Form 144 | IRhythm Technologies(IRTC.US) Officer Proposes to Sell 300K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 18, $iRhythm Technologies(IRTC.US)$ Officer MARK J DAY intends to sell 3,000 shares of its common stock on Jun 18, with a total market value of approximately $300K. Sour
Express News | IRhythm Technologies Shares Are Trading Higher After the Company Announced That It Reached a Corporate Milestone After It Launched the Initial Phases of Its Previously Disclosed Manufacturing Automation Plans
Express News | IRhythm Technologies Achieves Milestone After Launch Of Initial Phases Of Previously Disclosed Manufacturing Automation Plans
IRhythm Technologies Achieves Significant Operational Milestone With Launch of Initial Phase of Manufacturing Automation
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease,
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares soared 29.13% in the last week after reporting that its transf
J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday
U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Thursday.Shares of The J. M. Smucker Company (NYSE:SJM) rose sharply during Thursday's session following upbeat quarte
ACSD Granted Significant Telemedicine Patent
IRVINE, Calif., June 5, 2024 /PRNewswire/ -- ACS Diagnostics, Inc. of Irvine CA, with executive offices in Chattanooga TN, has been granted U.S Patent No. 11,980,452. The patent relates to ACSD's Car